Rheumatoid Arthritis (RA) (Dutch: Reumatoïde Artritis)
Conditions
Interventions
The strategy consists of decision supportive information, a ‘DAS-passport’ and support by a specialized rheumatology nurse.
Decision supportive information for patients
An important first step is to
Sponsors
Radboud university medical center
Eligibility
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a patient must meet all of the following criteria: - has RA according to the 1987 ACR criteria for RA - is treated for RA in the hospital where the study is performed, - is able to read or understand the Dutch language.
Exclusion criteria
Exclusion criteria: A patient will be excluded from participation in this study if her or she is in remission. Remission is defined as a DAS28 score < 2.6 for at least two times in a row.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of this study is patient empowerment measured with the Effective Consumer Scale (EC-17). | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes of this study are: - Knowledge about tight control, measured by a questionnaire - Attitude towards medication, measured by the Beliefs about Medicines Questionnaire (BMQ) - Tight control adherence and DAS28 decrease (data from medical files) Furthermore, possible confounding factors like age, gender, disease duration, prognostic factors (rheumatoid factor, erosions), previous RA medication and their highest level of education are measured. A process evaluation will be performed at the end of the study period. | — |
Contacts
Public ContactM. Jonge, de
Radboud University Medical Center Department IQ healthcare PO box 9101 (114) 6500 HB Nijmegen
Outcome results
None listed